Physician profile
Adam D Bell
NPI 1942463799
$9,788.27
in general payments reported to CMS, 2019-2025
15 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,859 · 2020: $574 · 2021: $3,346 · 2022: $1,387 · 2023: $1,114 · 2024: $275 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958 · Travel and Lodging: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.71 |
| Travel and Lodging | $665.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,608.04 | 2019-2024 | Da Vinci Surgical System |
| Stryker Corporation | $1,334.29 | 2021-2022 | |
| Tela Bio, INC. | $404.55 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Coopersurgical, INC. | $140.50 | 2025 | Onetrac Lx, Insorb |
| Innovation Technologies INC | $45.30 | 2020 | |
| Ethicon US, LLC | $39.92 | 2021-2023 | Endopath Xcel |
| Astrazeneca Pharmaceuticals LP | $39.84 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $32.05 | 2024 | Myrisk |
| Sawtooth Surgical Solutions INC | $31.37 | 2025 | |
| W. L. Gore & Associates, INC. | $24.62 | 2023 | Gore Synecor Biomaterial |
| Daiichi Sankyo INC. | $23.99 | 2024 | Enhertu |
| Mimedx Group, INC. | $20.62 | 2025 | |
| Janssen Biotech, INC. | $17.08 | 2024 | Simponi, Tremfya, Stelara |
| Alnylam Pharmaceuticals INC. | $14.18 | 2024 | Amvuttra |
| Pacira Pharmaceuticals Incorporated | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.